U.S. Professional Services Stock News

CoreCivic (NYSE:CXW) has amended its credit agreement to add a $100 million Incremental Term Loan. The company plans to use the proceeds to refinance outstanding revolver borrowings and for general corporate purposes. This financing step adjusts CoreCivic’s capital structure and affects its available liquidity profile. For investors watching CoreCivic at a current share price of $20.22, this credit agreement amendment is an important capital structure event. The stock shows mixed...

If you are wondering whether Akamai Technologies is fairly priced today, the key question is how its current share price compares with a grounded view of its long term cash generation. The stock closed at US$96.81, with an 11.7% decline over the last 7 days and an 8.5% decline over the last 30 days, while still showing a 13.8% return year to date and 31.8% over the last year. Recent headlines around Akamai often center on its role in content delivery, cloud security and edge computing, which...

PVH Corp., the owner of Calvin Klein and Tommy Hilfiger, recently outlined plans to offset a larger share of tariff costs through measures such as vendor negotiations, re-sourcing, and pricing changes, aiming to mitigate about three quarters of its tariff burden on an annualized basis by 2026. At the same time, PVH’s below-standard constant currency growth, stagnant returns on capital, and flat free cash flow margins underscore that tariff mitigation alone does not resolve the company’s...

C3.ai recently launched C3 Code, an agentic enterprise AI development platform that uses natural language prompts to automatically design, configure, test, and deploy production-grade applications across sectors such as manufacturing, energy, financial services, defense, utilities, and healthcare. The company highlighted an independent evaluation using Anthropic’s Claude that scored C3 Code 9.2 out of 10 overall, ahead of OpenAI’s Codex, Anthropic’s own Claude Code, and Palantir, with a...

In recent weeks, Viper Energy, Inc. received favorable attention from Wall Street, including analyst upgrades and its inclusion among preferred U.S. energy names, while shareholders also learned of a secondary offering by Diamondback Energy and a proposed bylaw change to allow certain investors to call special meetings. These developments collectively highlight growing institutional interest in Viper’s Permian-focused royalty model and evolving corporate governance framework. We’ll now...

If you are wondering whether Maplebear at US$41.74 is attractively priced or just riding a story, the valuation picture can help you sort substance from noise. The stock has returned 3.5% over the last 7 days and 9.4% over the last 30 days, set against a year to date return of 4.9% decline and a 1 year return of 2.9% decline. Recent headlines around Maplebear have focused on its position in consumer retailing and how investors are weighing growth potential against execution risks. This...

Stock performance snapshot Cohu (COHU) has attracted attention after a strong run, with the share price at $39.37 and gains over the past day, week, month, and 3 months all in positive territory based on the provided returns. See our latest analysis for Cohu. The recent 1 month share price return of 36.32% and year to date share price return of 59.98% sit against a 1 year total shareholder return of 180.01%. This points to strong momentum building after a slower multi year record. If you are...

Earnings surprise lifts interest in United Natural Foods stock United Natural Foods (UNFI) recently reported quarterly results, with revenue down 2.6% year on year and below analyst expectations, while EBITDA came in ahead of forecasts, a mix that has drawn fresh attention to the stock. See our latest analysis for United Natural Foods. The mixed earnings report appears to have reset expectations, with the stock posting a 17.0% 1 month share price return and a 40.6% year to date share price...

On 16 April 2026, Medline announced a new agreement to pilot Symbotic's AI-powered warehouse automation system at a U.S. distribution center in 2027, marking the first use of this technology in the healthcare supply chain. This move highlights how Symbotic's robotics platform is extending beyond retail into healthcare logistics, underscoring its flexibility across complex, high-stakes distribution networks. Next, we'll examine how entering healthcare logistics with Medline could reshape...

Event context and recent share performance Assurant (AIZ) has come into focus after recent share price moves, with the stock closing at $224.65. Short term returns are modestly positive, while performance over the past 3 months and year to date has been weaker. See our latest analysis for Assurant. The recent 1 month share price return of 3.37% contrasts with weaker 3 month and year to date share price returns. At the same time, a 1 year total shareholder return of 20.75% highlights...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Vertical Aerospace (NYSE:EVTL) has drawn fresh attention after completing a two-way piloted transition flight in its full-scale tiltrotor eVTOL. This is a key step that validates its electric air taxi concept under civil aviation oversight. See our latest analysis for Vertical Aerospace. The successful transition flight has arrived alongside sharp short term share price momentum, with a 1 day share price return of 25.56% and 7 day return of 45.22%. However, this sits against a weaker 90 day...

Clearway Energy is asking stockholders to approve a plan to consolidate its public share classes into a single share class. The company is seeking this approval at an upcoming stockholder meeting as part of an effort to simplify its equity structure. Proxy advisory firm ISS has recommended that investors vote "FOR" the proposed share class unification. For investors tracking NYSE:CWEN.A, the proposal comes as Clearway Energy trades at a share price of $39.98 and carries a value score of 3...

RBC Capital Markets’ decision to lift its 2026 funds from operations estimate for American Healthcare REIT (AHR) to US$2.04 per share, tied to a higher investment pace, has put fresh attention on the stock. See our latest analysis for American Healthcare REIT. The latest analyst revision comes as American Healthcare REIT trades at US$50.58, with a 1-day share price return of 2.22% and a 7-day share price return of 2.99%. The 1-year total shareholder return of 69.18% points to strong momentum...

Wondering if Nabors Industries at around US$82.24 is priced for its risks or offering genuine value? This article focuses squarely on what the current share price could mean for you. The stock is roughly flat over the last week with a 0.8% decline, but is up 3.0% over 30 days and 48.4% year to date, while the 1 year return sits at 166.1% against weaker 3 year and 5 year returns of 28.3% and 1.3% declines. Recent trading interest reflects how investors are reassessing Nabors Industries after...

Exelixis (EXEL) is drawing attention after recent trading, with shares last closing at $44.38. For investors, the key questions now center on how the company’s current valuation lines up with its fundamentals. See our latest analysis for Exelixis. While the 7 day share price return of 2.27% is soft, a 30 day share price return of 6.10% alongside a 1 year total shareholder return of 22.63% points to momentum that has built over a longer horizon. If you want to see how other cancer and biotech...

If you are wondering whether Walmart's share price still offers value after a long run, or if you might be late to the story, this article breaks down what the current valuation suggests about the stock. Walmart's shares most recently closed at US$124.82, with returns of 10.7% year to date and 35.1% over the last year, even after a 3.3% decline over the past week and a 0.2% slip over the last month. Recent headlines around Walmart have focused on its role as a major consumer retailer,...

Bank of America (NYSE:BAC) reports its strongest quarterly results in nearly two decades for Q1 2026. Earnings per share are 25% higher year-over-year, with revenue growth of 7%. Equities trading reaches record levels, alongside double digit gains in investment banking and wealth management. Management highlights AI driven tools, including Meeting Journey AI, as material contributors to performance and efficiency. For a large universal bank like Bank of America, these Q1 2026 results show...

Morgan Stanley ( NYSE:MS ) just released its latest quarterly results and things are looking bullish. Morgan Stanley...

Vontier (NYSE:VNT) has appointed Denice Biocca as Chief People Officer. Biocca will oversee global HR operations, talent development, and employee engagement for more than 8,000 employees. She joins Vontier with extensive HR leadership experience at GE and GE Vernova, including work on acquisitions and organizational transformations. For investors watching Vontier, this move comes with the stock at a share price of $36.47 and a 1 year return of 21.7%. Over 3 years the stock has returned...

Hagerty’s Broad Arrow Auctions unit recently highlighted its role in the collector car space by presenting rare modern supercars and hypercars at the Concorso d’Eleganza Villa d’Este Auction, while director Laurie Harris sold 5,531 shares to cover tax obligations tied to restricted stock vesting and retained 36,689 Class A shares. These developments reinforce Hagerty’s expanding presence in high-end enthusiast events and clarify that recent insider selling was administrative rather than a...

Wondering if Allegiant Travel's current share price still offers value, or if the easy gains are behind it? This article walks through the numbers in plain terms so you can judge for yourself. After a strong 90.8% return over the last year, the stock has recently been more mixed, with a 3.0% decline over the last 7 days, a 5.3% gain over the last 30 days, and a 4.3% year to date decline from a last close of US$84.24. Recent coverage has focused on Allegiant Travel's position within the...

If you are wondering whether Incyte’s current share price lines up with its underlying worth, the key question is how the market is valuing its future cash flows and growth potential. The stock most recently closed at US$95.32, with returns of 1.2% over 30 days, a 6.0% decline year to date, and 63.8% over the past year, which can change how investors think about both upside and risk. Recent news around Incyte has focused on its pipeline progress and partnerships, which often influences how...

If you are wondering whether MarketAxess Holdings at around US$173.50 is a potential opportunity or a value trap, it helps to start by breaking its current share price into clear valuation building blocks. The stock has posted a 0.4% return over the past week, but is still showing a 3.1% decline over 30 days, a 2.8% decline year to date, and a 21.7% decline over the past year, extending to 45.7% over 3 years and 63.4% over 5 years. These moves sit against a backdrop where MarketAxess...